Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 0 results

Large-scale testing (Phase 3)UnknownNCT00002763
What this trial is testing

High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma

Who this might be right for
Melanoma (Skin)
European Organisation for Research and Treatment of Cancer - EORTC 1,000
Not applicableNo Longer AvailableNCT04289155
What this trial is testing

Individual Patient Compassionate Use of GX-I7

Who this might be right for
GlioblastomaHigh Grade GliomaRecurrent Glioblastoma+2 more
Genexine, Inc.
Very early researchLooking for participantsNCT07586904
What this trial is testing

Efficacy and Safety of Neoadjuvant Cadonilimab Plus High-Dose Recombinant Human Interferon α1b in Stage III/IV Melanoma.

Who this might be right for
Melanoma (Skin Cancer)
Xijing Hospital 10
Large-scale testing (Phase 3)Ended earlyNCT00036816
What this trial is testing

Vaccine Therapy in Treating Patients With Melanoma of the Eye

Who this might be right for
Intraocular Melanoma
European Organisation for Research and Treatment of Cancer - EORTC 13
Testing effectiveness (Phase 2)Study completedNCT04133948
What this trial is testing

Multicenter Phase 1b Trial Testing the Neoadjuvant Combination of Domatinostat, Nivolumab and Ipilimumab in IFN-gamma Signature-low and IFN-gamma Signature-high RECIST 1.1-measurable Stage III Cutaneous or Unknown Primary Melanoma

Who this might be right for
Malignant Melanoma Stage III
The Netherlands Cancer Institute 44
Not applicableStudy completedNCT00912418
What this trial is testing

Pilot Study for the Evaluation of the Efficacy of Vaccination With Autologous Tumor Cells Plus Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) - in - Adjuvant, Followed by Systemic Low-dose-interleukin-2 (IL-2) Administration, in Patients With High Risk Melanoma

Who this might be right for
Melanoma
Craig L Slingluff, Jr 14
Early research (Phase 1)Study completedNCT00457418
What this trial is testing

High-Dose PEG-Intron Pharmacokinetic Study in Patients With Melanoma (Study P04831 AM2)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 32
Not applicableUnknownNCT02907827
What this trial is testing

Whole-body DW-MRI and cfDNA Analysis for the Surveillance of Melanoma Patients at High Risk for Recurrence.

Who this might be right for
Melanoma
Universitair Ziekenhuis Brussel 100
Not applicableStudy completedNCT00897520
What this trial is testing

Biomarkers in Patients With High-Risk Melanoma Receiving High-Dose Interferon Therapy

Who this might be right for
Melanoma (Skin)
ECOG-ACRIN Cancer Research Group 40
Large-scale testing (Phase 3)Study completedNCT02843386
What this trial is testing

Comparison Between Fotemustin to Intensive Surveillance in Patients With High Risk Uveal Melanoma

Who this might be right for
Uveal Melanoma
Institut Curie 302
Testing effectiveness (Phase 2)Looking for participantsNCT04114136
What this trial is testing

Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies

Who this might be right for
MelanomaNSCLCHepatocellular Carcinoma+5 more
Dan Zandberg 72
Testing effectiveness (Phase 2)Looking for participantsNCT06630611
What this trial is testing

Evaluation of a Pragmatic Approach to Adoptive Cell Therapy (ACT) Using an IL2 Analog (ANV419) vs High Dose IL2 After Tumor Infiltrating Lymphocytes (TIL) Therapy in Patients With Melanoma, NSCLC and Cervical Cancer (PragmaTIL)

Who this might be right for
MelanomaNon Small Cell Lung CancerCervical Cancer
Vall d'Hebron Institute of Oncology 40
Testing effectiveness (Phase 2)Study completedNCT00463892
What this trial is testing

High-resolution Magnetic Resonance Imaging (MRI) Scans to Look for Spread of Melanoma to Nearby Lymph Nodes

Who this might be right for
Melanoma
Redwood Regional Medical Group 200
Testing effectiveness (Phase 2)Ended earlyNCT01874119
What this trial is testing

Fosaprepitant for N/V With High-dose Interleukin-2 for Metastatic Melanoma and Renal Cell Carcinoma

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
St. Louis University 13